Cai, Sidong
Chang, Junlei
Su, Mengqi
Wei, Yinxia
Sun, Haoran
Chen, Cong http://orcid.org/0000-0001-9076-3148
Yiu, Kai-Hang
Funding for this research was provided by:
Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515111093, 2023A1515010731)
National Natural Science Foundation of China (82270400)
Program of the Shenzhen Municipal Science and Technology Commission (JCYJ20210324114808024)
Sanming Project of Medicine in Shenzhen (SZSM201911020)
HKU-SZH Fund for Shenzhen Key Medical Discipline (SZXK2020081)
Article History
Received: 21 April 2023
Revised: 5 September 2023
Accepted: 27 September 2023
First Online: 11 November 2023
Declarations
:
: All authors declared no financial or scientific conflicts of interest with regard to the research described in this manuscript.
: All animal experiments were approved by the Ethics Committee of the University of Hong Kong, Shenzhen Hospital (2022-07-25, No: [2022]160), the ethical principles established by the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8523, revised 2011) were followed. Besides, retrospective study on the miR-455-5p on patients with hypertensive heart disease was performed in line with the principles of the Declaration of Helsinki and was approved by the Ethics Committee of the University of Hong Kong, Shenzhen Hospital (2022-06-28, No: [2022]134). All experiments in this study comply with the current laws of the country.
: Informed consent was obtained from all individual participants included in the study.